Atara Biotherapeutics Inc at Cowen Virtual Oncology Innovation Summit Transcript
Good afternoon and welcome once again to Cowen and Company's 2nd Annual Oncology Innovation Summit. I'm Phil Nadeau, one of the biotech analysts here at Cowen, and it's my pleasure to moderate the session with Atara Biotherapeutics.
I'm very happy to have with us today Pascal Touchon, the President and CEO; and AJ Joshi, the CMO.
Questions & Answers
First, I believe we'll start with Tab-cel. On your recent earnings call, you provided meaningful updates on the ALLELE trial as well as the status of your BLA. Could you briefly review those for us?
Yes, certainly. AJ, do you want to start about the ALLELE trial and then I will talk about the BLA status?
Sure. So, the update that we provided was primarily around a recent review of the data. Remember, what we had discussed
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |